Pages that link to "Q39366175"
Jump to navigation
Jump to search
The following pages link to Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control (Q39366175):
Displaying 7 items.
- Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma. (Q37633722) (← links)
- Application of nitric oxide measurements in clinical conditions beyond asthma (Q38670757) (← links)
- Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy (Q39506975) (← links)
- Biological clocks: their relevance to immune-allergic diseases. (Q47644009) (← links)
- Utility of Exhaled Nitric Oxide Fraction for the Diagnosis of Hypersensitivity Pneumonitis. (Q51574089) (← links)
- Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy (Q57585034) (← links)
- Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma (Q91964998) (← links)